GHO 24-hour amplitude reaches 42.2% with a high of $1.42: mainly low liquidity fluctuations, no clear driving event
Bitget Pulse2026/03/11 18:06Volatility Overview
In the past 24 hours, the price of GHO rebounded from a low of $0.9985 to a high of $1.42 and is currently quoted at $1.42, with a volatility of up to 42.2%. Mainstream platform data shows actual trading volume of about $2 million, with the price stabilizing near $1.00 (24-hour high $1.00, low $0.999), and no abnormal records of net fund inflow/outflow.
Brief Analysis of Abnormal Price Movement Causes
• No official announcements, news events, or on-chain data (such as mint/burn anomalies or whale transfers) were found in the past 24 hours that directly pushed the price to $1.42.
• It may originate from price deviations in certain low-liquidity DEX pools, while mainstream CEX/aggregator quotes remain stable around the $1 peg.
Market View and Outlook
The market and community have shown no significant discussions about GHO recently; there have been no related crypto GHO posts on Twitter in the past 24 hours. The mainstream view regards it as a stablecoin, expecting it to maintain its $1 peg, with no future outlook or risk warnings mentioned.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring, and is for informational reference only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Samsung Partners With Solana to Launch Crypto Stablecoin Payments for 82 Million Americans via Samsung Wallet
JPMorgan CEO Dimon Issues Another Warning on the Bond Market: Corporate Borrowers Will Start to Face Pressure
The global competition for capital may begin to squeeze corporate borrowers.
APLD Revenue Surges 322%: Is AI Data Center Expansion Starting to Pay Off?
Revenue surges by 42% and returns to profitability! Artificial disc leader Centinel Spine races for US IPO as innovative medical devices face valuation test
Centinel Spine is a medical device company headquartered in West Chester, Pennsylvania, USA, specializing in Total Disc Replacement (TDR). Its core prodisc platform covers artificial cervical and lumbar discs, aiming to replace diseased discs while preserving the mobility of the treated segment and providing an alternative treatment option to spinal fusion surgery for eligible patients.